BTIG Reiterates Buy on Coya Therapeutics, Maintains $16 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 85.9%

Neg 0% Neu 85.9% Pos 0%

BTIG analyst Thomas Shrader reiterates Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $16 price target.

Comments

No comments yet. Be the first!